Cargando…

Review of the Clinical Evidences of Modulated Electro-Hyperthermia (mEHT) Method: An Update for the Practicing Oncologist

Background: Modulated electro-hyperthermia (mEHT) is a variation of the conventional hyperthermia which selectively targets the malignant cell membranes in order to heat the malignant tissue and sensitize the tissue to oncology treatments. Although widely applied, the formulation of guidelines for t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szasz, Attila M., Minnaar, Carrie Anne, Szentmártoni, Gyongyver, Szigeti, Gyula P., Dank, Magdolna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837995/ https://www.ncbi.nlm.nih.gov/pubmed/31737558 http://dx.doi.org/10.3389/fonc.2019.01012

Ejemplares similares

The Clinical Validation of Modulated Electro-Hyperthermia (mEHT)
por: Lee, Sun-Young, et al.
Publicado: (2023)

Effects of Modulated Electro-Hyperthermia (mEHT) on Two and Three Year Survival of Locally Advanced Cervical Cancer Patients
por: Minnaar, Carrie Anne, et al.
Publicado: (2022)

Modulated Electro-Hyperthermic (mEHT) Treatment in the Therapy of Inoperable Pancreatic Cancer Patients—A Single-Center Case-Control Study
por: Petenyi, Flora Greta, et al.
Publicado: (2021)

Quo Vadis Oncological Hyperthermia (2020)?
por: Lee, Sun-Young, et al.
Publicado: (2020)

Meta-Analysis of Modulated Electro-Hyperthermia and Tumor Treating Fields in the Treatment of Glioblastomas
por: Szasz, Attila Marcell, et al.
Publicado: (2023)

Influence of the duration of type 2 diabetes mellitus on colorectal cancer outcomes
por: Herold, Magdolna, et al.
Publicado: (2023)

Potentiation of the Abscopal Effect by Modulated Electro-Hyperthermia in Locally Advanced Cervical Cancer Patients
por: Minnaar, Carrie Anne, et al.
Publicado: (2020)

Morphological and pathological response in primary systemic therapy of patients with breast cancer and the prediction of disease free survival: a single center observational study
por: Szentmártoni, Gyöngyvér, et al.
Publicado: (2016)

Oncological hyperthermia: The correct dosing in clinical applications
por: Lee, Sun-Young, et al.
Publicado: (2018)

Successful treatment of three synchronous primary malignant tumours—reflection on surgical, pathological and oncological aspects and decision making
por: Ágoston, Emese Irma, et al.
Publicado: (2018)

Hyperthermia versus Oncothermia: Cellular Effects in Complementary Cancer Therapy
por: Hegyi, Gabriella, et al.
Publicado: (2013)

Commentary on "Systematic review about complementary medical hyperthermia in oncology" by Liebl et al.
por: Arrojo, Elisabeth, et al.
Publicado: (2022)

Evidence based tools to improve efficiency of currently administered oncotherapies for tumors of the hepatopancreatobiliary system
por: Herold, Zoltan, et al.
Publicado: (2021)

Prognostic and Clinicopathological Correlations of Cell Cycle Marker Expressions before and after the Primary Systemic Therapy of Breast Cancer
por: Tőkés, Tímea, et al.
Publicado: (2019)

Response evaluation after primary systemic therapy of Her2 positive breast cancer – an observational cross-sectional study
por: Tőkés, Tímea, et al.
Publicado: (2015)

Longitudinal Analysis of 1α,25-dihidroxyvitamin D(3) and Homocysteine Changes in Colorectal Cancer
por: Mühl, Dorottya, et al.
Publicado: (2022)

Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer?
por: Dank, Magdolna, et al.
Publicado: (2022)

Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancer
por: Herold, Zoltan, et al.
Publicado: (2022)

Relationship between Energy Dosage and Apoptotic Cell Death by Modulated Electro-Hyperthermia
por: Kao, Patrick Hung-Ju, et al.
Publicado: (2020)

High plasma CD40 ligand level is associated with more advanced stages and worse prognosis in colorectal cancer
por: Herold, Zoltan, et al.
Publicado: (2022)

Thymosin β4 Improves Differentiation and Vascularization of EHTs
por: Ziegler, Tilman, et al.
Publicado: (2017)

In vitro comparison of conventional hyperthermia and modulated electro-hyperthermia
por: Yang, Kai-Lin, et al.
Publicado: (2016)

Forcing the Antitumor Effects of HSPs Using a Modulated Electric Field
por: Minnaar, Carrie Anne, et al.
Publicado: (2022)

Development of LTS and HTS Superconductors for Accelerator Magnets at EAS and EHTS
por: Krauth, H
Publicado: (2005)

Comparison of the effectiveness of integrative immunomodulatory treatments and conventional therapies on the survival of selected gastrointestinal cancer patients
por: Kleef, Ralf, et al.
Publicado: (2023)

Modulated Electro-Hyperthermia Facilitates NK-Cell Infiltration and Growth Arrest of Human A2058 Melanoma in a Xenograft Model
por: Vancsik, Tamás, et al.
Publicado: (2021)

Suppression of Metastatic Melanoma Growth in Lung by Modulated Electro-Hyperthermia Monitored by a Minimally Invasive Heat Stress Testing Approach in Mice
por: Thomas, Mbuotidem Jeremiah, et al.
Publicado: (2020)

Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study
por: Ranieri, Girolamo, et al.
Publicado: (2020)

Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy
por: Tsang, Yuk-Wah, et al.
Publicado: (2015)

The effect of modulated electro-hyperthermia on local disease control in HIV-positive and -negative cervical cancer women in South Africa: Early results from a phase III randomised controlled trial
por: Minnaar, Carrie Anne, et al.
Publicado: (2019)

Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study
por: Ranieri, Girolamo, et al.
Publicado: (2021)

Integrating Hyperthermia into Modern Radiation Oncology: What Evidence Is Necessary?
por: Peeken, Jan C., et al.
Publicado: (2017)

Modulated Electro-Hyperthermia Supports the Effect of Gemcitabine Both in Sensitive and Resistant Pancreas Adenocarcinoma Cell Lines
por: Forika, Gertrud, et al.
Publicado: (2021)

Extracorporeal Hyperoxygenation Therapy (EHT) for Carbon Monoxide Poisoning: In-Vitro Proof of Principle
por: Steuer, Niklas B., et al.
Publicado: (2021)

Patients with Metachronous Peritoneal Metastatic Mucinous Colorectal Adenocarcinoma Benefit More from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) than Their Synchronous Counterparts
por: Herold, Zoltan, et al.
Publicado: (2022)

Deep Learning: A Review for the Radiation Oncologist
por: Boldrini, Luca, et al.
Publicado: (2019)

Pitfalls of FDG-PET in the prostate for the surgical oncologist
por: O'Connor, Ellen, et al.
Publicado: (2020)

Erratum: Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations
por: Brown, David, et al.
Publicado: (2017)

Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations
por: Brown, David, et al.
Publicado: (2017)

Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases
por: Steinhoff, Heinrich, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_skonoame4g5ub410b5591gqqkp